Aminolevulinate

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear.

Drug facts

Used for: Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

Detailed sections are not available in this stored label.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Aminolevulinate; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/aminolevulinate
APA 7th: sofidex. (2026, August 3). Aminolevulinate. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/aminolevulinate
AMA 11th: Aminolevulinate. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/aminolevulinate

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.